9th November 2016
Innovative biotechnology company, Axim Biotechnologies Inc has appointed Grayling in the US to support its Investor Relations and Public Relations’ needs.
Axim Biotechnologies is engaged in the research and development, and production of pharmaceutical, nutriceutical and cosmetic products, as well as the procurement of genetically and nano-controlled active ingredients. The company’s particular focus is on the development of treatments for pain, spasticity, anxiety and other medical disorders using cannabinoids-based products. Pharmaceutical R&D aims to deliver systems and active pharmaceutical ingredients for treating conditions such as Parkinson's disease, Alzheimer's disease, restless leg syndrome and Crohn's disease.
Presently, the company is conducting clinical studies of MedChewRx, a pharmaceutical chewing gum containing cannabinoids. The company is in the process of getting FDA and EMA regulatory approval to launch this product in 2017, and it is in regard to this that Grayling is providing support.
Grayling’s efforts will be driven by New York based executive vice president, Lucia Domville. She says: “This is a fascinating company that is really pushing the boundaries with its research, and we are thrilled to be their partner.”
7th February 2018
EVENT 14 Feb: Grayling Engage - Delivering Effective Consultation and Community Engagement Breakfast Briefing
Grayling Engage and Grayling Manchester are jointly hosting a networking breakfast for senior communications and engagement experts that will share findings from our recently published State of...Read More
29th November 2017
Grayling's Meakin elected to serve on international board of comms industry measurement and evaluation body
Grayling's global head of strategic services, Jon Meakin has been elected to the International Board of the Association for the Measurement and Evaluation of Communications (AMEC). AMEC...Read More
22nd August 2017
Emerging trends in the professional services sector
There is no escaping the fact that in terms of public profile the next few years will be critical for the professional services sector, not least because of the current economic and political climate,...Read More